These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 8671966

  • 1. IgA nephropathy in patients over 50 years of age: a multicentre, prospective study.
    Frimat L, Hestin D, Aymard B, Mayeux D, Renoult E, Kessler M.
    Nephrol Dial Transplant; 1996 Jun; 11(6):1043-7. PubMed ID: 8671966
    [Abstract] [Full Text] [Related]

  • 2. [IgA nephropathy in patients above 45 years of age. Clinical and morphologic analysis].
    Wagrowska-Danilewicz M, Danilewicz M, Szemraj M.
    Pol Merkur Lekarski; 1997 Sep; 3(15):115-8. PubMed ID: 9461706
    [Abstract] [Full Text] [Related]

  • 3. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

  • 4. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF.
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [Abstract] [Full Text] [Related]

  • 5. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [Abstract] [Full Text] [Related]

  • 6. Factors predicting progression of IgA nephropathies.
    Coppo R, D'Amico G.
    J Nephrol; 2005 Sep; 18(5):503-12. PubMed ID: 16299675
    [Abstract] [Full Text] [Related]

  • 7. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP.
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [Abstract] [Full Text] [Related]

  • 8. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H, Fujimoto S, Sato Y, Hara S, Yamada K, Morita S, Eto T.
    J Nephrol; 2005 Jun; 18(6):690-5. PubMed ID: 16358226
    [Abstract] [Full Text] [Related]

  • 9. Clinical features and natural history of IgA nephropathy.
    Rychlik I, Andrassy K, Waldherr R, Zuna I, Tesar V, Jancová E, Stejskalová A, Ritz E.
    Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
    [Abstract] [Full Text] [Related]

  • 10. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
    Espinosa M, Ortega R, Gómez-Carrasco JM, López-Rubio F, López-Andreu M, López-Oliva MO, Aljama P.
    Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
    [Abstract] [Full Text] [Related]

  • 11. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors in immunoglobulin-A nephropathy.
    Muthukumar T, Fernando ME, Jayakumar M.
    J Assoc Physicians India; 2002 Nov; 50():1354-9. PubMed ID: 12583461
    [Abstract] [Full Text] [Related]

  • 13. [Renal vascular lesions and the occurrence of hypertension in patients with IgA nephropathy].
    Boulahrouz R, Stanescu C, Charasse C, Ang KS, Le Cacheux P, Leonetti F, Rioux N, Ramee MP, Simon P.
    Arch Mal Coeur Vaiss; 2004 Nov; 97(7-8):782-5. PubMed ID: 15506066
    [Abstract] [Full Text] [Related]

  • 14. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 Nov; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 15. Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy?
    Lai KN, Ho CP, Chan KW, Yan KW, Lai FM, Vallance-Owen J.
    Q J Med; 1985 Oct; 57(222):677-88. PubMed ID: 4080957
    [Abstract] [Full Text] [Related]

  • 16. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study.
    Wakai K, Kawamura T, Endoh M, Kojima M, Tomino Y, Tamakoshi A, Ohno Y, Inaba Y, Sakai H.
    Nephrol Dial Transplant; 2006 Oct; 21(10):2800-8. PubMed ID: 16822793
    [Abstract] [Full Text] [Related]

  • 17. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [Abstract] [Full Text] [Related]

  • 18. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
    Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Eto T, Nakao H.
    Ren Fail; 2005 Nov; 27(1):45-52. PubMed ID: 15717634
    [Abstract] [Full Text] [Related]

  • 19. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
    Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, Park SY, Han JS, Kim S, Lee JS.
    Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
    [Abstract] [Full Text] [Related]

  • 20. Can immunosuppressive drugs slow the progression of IgA nephropathy?
    Goumenos D, Ahuja M, Shortland JR, Brown CB.
    Nephrol Dial Transplant; 1995 Feb; 10(7):1173-81. PubMed ID: 7478120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.